Latest News

Filters

Filter by tags: Research reactor United States Clear all tag filters

31 news articles found


The President of Brazil’s National Nuclear Energy Commission (CNEN - Comissào National de Energia Nuclear), Francisco Rondinelli Jr, during a visit to Argentina, signed a Memorandum of Understanding (MOU) with the President of the Argentine Atomic Energy Commission (CNEA - Comisión Nacional de Energía Atómica), Adriana Serquis, to strengthen bilateral cooperation in the peaceful use of nuclear technology.

Date: Wednesday, 11 October 2023
Original article: neimagazine.com/news/newsargentina-and-brazil-strengthen-nuclear-cooperation-11206965

Advances in emerging field of ‘theranostics’ are a game-changer Millions of patients around the globe rely on the regular and timely production of diagnostic and therapeutic isotopes produced in research reactors and accelerator facilities. Image courtesy IAEA. Advances in medical isotope diagnostics and therapy are holding promise for cancer patients, despite challenges facing the nuclear medical field in recent years related to radionuclide production and supply, rising costs, and stricter regulation.

Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.

Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.

According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.

Date: Friday, 14 April 2023
Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023

Japan's last high-enriched uranium (HEU)-fuelled research reactor is to be converted to low-enriched uranium (LEU) fuel under a new agreement between the US Department of Energy National Nuclear Security Administration (NNSA) and Japan’s Ministry of Education, Culture, Sports, Science and Technology (MEXT).

Date: Friday, 30 September 2022
Original article: world-nuclear-news.org/Articles/Final-Japanese-research-reactor-to-convert-to-LEU

The International Atomic Energy Agency (IAEA) has conducted its first Integrated Research Reactor Utilization Review (IRRUR) mission. An international team of experts carried out a thorough assessment of the way in which Chile's RECH-1 research reactor is currently being used and its potential capabilities.

Date: Thursday, 21 July 2022
Original article: world-nuclear-news.org/Articles/IAEA-team-assesses-utilisation-of-Chilean-research

The high flux research reactor at Petten in the Netherlands. Courtesy NRG. US-based Terrestrial Energy and the Nuclear Research and Consultancy Group (NRG) have started a graphite irradiation testing programme for the Integral Molten Salt Reactor power plant at NRG’s high flux research reactor (HFR) at Petten in the Netherlands.

The work is part of broader programme of testing of components and systems for the IMSR plant, which uses Generation IV reactor technology for electric power generation and heat for industrial heat applications.

The testing programme at the HFR, one of the most powerful multi-purpose research and test reactors in the world, is designed to confirm the predicted performance of selected graphite grades throughout the seven-year cycle of the IMSR core-unit.

The testing will simulate IMSR core conditions, encompassing the full range of IMSR operating temperatures and of the neutron flux. NRG said the HFR has reached full power indicating the successful start of the test programme.

Date: Saturday, 14 November 2020
Original article: nucnet.org/news/terrestrial-energy-and-nrg-begin-graphite-irradiation-testing-at-petten-11-5-2020

Of the 220 research reactors in operation today, only seven are on the African continent. In other words, with 17.2% of the world population and the strongest expected growth in the coming years, Africans have access to only 3% of the world's nuclear research reactor capacity. Marguerite Leonardi, senior advisor at NPC Consulting & Engineering, and Professor Vincent Lukanda Mwamba, Commissaire Général of the Commissariat Général à l’Energie Atomique, explain why that is a concern and why the research reactor in Kinshasa should be restarted urgently.

Date: Tuesday, 13 October 2020
Original article: world-nuclear-news.org/Articles/Viewpoint-Why-research-reactors-are-so-important-f

Russia’s BP Konstantinova Petersburg Institute of Nuclear Physics has announced a tender for the development of a core design for the PIK research reactor in Gatchina, RosTender.info reported on 7 July.

Date: Friday, 10 July 2020
Original article: neimagazine.com/news/newstender-announced-to-provide-fuel-for-russias-pik-reactor-8018410

France's Framatome and the Technical University of Munich (TUM) in Germany have started commercial development of nuclear research reactor fuels based on uranium-molybdenum fuel (U-Mo) alloys. The fuel can be used instead of highly enriched uranium (HEU), which is seen as a potential nuclear proliferation risk.

Date: Wednesday, 06 May 2020
Original article: world-nuclear-news.org/Articles/Framatome-TUM-to-develop-new-research-reactor-fuel

The head of the Atomic Energy Organisation of Iran (AEOI), Ali Akbar Salehi, said on 8 April in a message marking National Nuclear Technology Day that Iran’s nuclear activities were continuing despite the novel coronavirus outbreak and continuing US sanctions.

Date: Wednesday, 15 April 2020
Original article: neimagazine.com/news/newsiran-pushes-ahead-with-nuclear-development-despite-pandemic-restrictions-7871976